Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / BHC - Satsuma Pharmaceuticals Files For U.S. IPO

BHC - Satsuma Pharmaceuticals Files For U.S. IPO

Bausch Health Companies Inc.

Quick Take

Satsuma Pharmaceuticals (STSA) has filed to raise gross proceeds of $86.25 million from a U.S. IPO, according to an S-1 registration statement.

The firm is focused on the development of a treatment of acute migraine headache.

STSA has begun Phase 3 trials and expects to publish initial topline results by the second half of 2020.

Company & Technology

San Francisco, California-based Satsuma Pharmaceuticals was founded in 2016 to develop and commercialize an acute treatment for migraine headaches.

Management is headed by co-founder, CEO and Director John Kollins, who was

Read more ...
Stock Information
Company Name: Bausch Health Companies Inc.
Stock Symbol: BHC
Market: NYSE
Website: bauschhealth.com
Menu
BHC BHC Quote BHC Short BHC News BHC Articles BHC Message Board
Get BHC Alerts

News, Short Squeeze, Breakout and More Instantly...